Katherine Boothe
Katherine Boothe
Associate Professor of Political Science, McMaster University
No verified email
Title
Cited by
Cited by
Year
Universal prescription drug coverage in Canada: Long-promised yet undelivered
SG Morgan, K Boothe
Healthcare management forum 29 (6), 247-254, 2016
542016
Toward an understanding of high performance pharmaceutical policy systems: a “triple-a” framework and example analysis
S Morgan, J Kennedy, K Boothe, M McMahon, D Watson, E Roughead
The Open Health Services and Policy Journal 2 (1), 2009
342009
The influence of institutions on issue definition: Children's environmental health policy in the United States and Canada
K Boothe, K Harrison
Journal of Comparative Policy Analysis 11 (3), 287-307, 2009
212009
Prescription drug subsidies in Australia and New Zealand
S Morgan, K Boothe
192010
Ideas and the limits on program expansion: the failure of nationwide pharmacare in Canada since 1944
K Boothe
Canadian Journal of Political Science/Revue canadienne de science politique …, 2013
152013
How the pace of change affects the scope of reform: pharmaceutical insurance in Canada, Australia, and the United Kingdom
K Boothe
Journal of Health Politics, Policy and Law 37 (5), 779-814, 2012
152012
Ideas and the pace of change: national pharmaceutical insurance in Canada, Australia, and the United Kingdom
K Boothe
University of Toronto Press, 2015
142015
“Getting to the table”: Changing ideas about public and patient involvement in Canadian drug assessment
K Boothe
Journal of health politics, policy and law 44 (4), 631-663, 2019
82019
Pharmaceutical policy reform in Canada: lessons from history
K Boothe
Health Economics, Policy and Law 13 (3-4), 299-322, 2018
22018
Pharmaceutical programs and social policy development: comparing Canada, Australia and the UK
K Boothe
University of British Columbia, 2010
22010
PHP25 TOWARD HIGH PERFORMANCE ‘PHARMACARE’SYSTEMS: A REVIEW OF EXPERIENCES IN SEVEN COUNTRIES
S Morgan, J Kennedy, L Roughead, K Boothe, M McMahon, D Watson
Value in Health 11 (3), A36, 2008
22008
Evaluating the Cost-effectiveness of Pharmaceuticals in Canada
K Boothe
Health Reform Observer–Observatoire des Réformes de Santé 4 (1), 2016
12016
(Re) defining legitimacy in Canadian drug assessment policy? Comparing ideas over time
K Boothe
Health Economics, Policy and Law, 1-16, 2021
2021
Ideas and the Pace of Change
K Boothe
Ideas and the Pace of Change, 2018
2018
5 Opportunities for Minor Change
K Boothe
Ideas and the Pace of Change, 120-139, 2018
2018
2 Explaining Stability and Change
K Boothe
Ideas and the Pace of Change, 19-46, 2018
2018
3 Radical Reform or Incrementalism
K Boothe
Ideas and the Pace of Change, 47-82, 2018
2018
7 Conclusion
K Boothe
Ideas and the Pace of Change, 163-176, 2018
2018
6 Explaining Major Change: Rare Conditions for Program Expansion
K Boothe
Ideas and the Pace of Change, 140-162, 2018
2018
4 Entrenched Ideas and Barriers to Major Change
K Boothe
Ideas and the Pace of Change, 83-119, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20